semaglutide alcohol cravings cuts but not daily drinks in Phase II trial Can Ozempic and Wegovy Help

These positive changes in lipid levels can reduce cardiovascular risk

In the Phase 2 trial, weight loss continued at 48 weeks across all dose groups, suggesting retatrutide may not plateau as single-receptor medications often do

Baseline body makeup influences the magnitude and timeline of changes, with subjects starting at higher body fat percentages possibly showing more rapid fat loss

Herrmann AP, Andrejew R, Benvenutti R, Gama CS, Elisabetsky E

In some cases, for example, it may make sense to offer family sizes of protein-rich or high-fiber foods and beverages

Risk increases when combined with sulfonylureas or insulin, requiring dose adjustment of concomitant hypoglycemic agents